金域医学：10月29日召开董事会会议

Group 1 - The core point of the article is that Kingmed Diagnostics (SH 603882) announced the convening of its fourth board meeting on October 29, 2025, to review its Q3 2025 report [1] - For the year 2024, the revenue composition of Kingmed Diagnostics is 92.17% from third-party medical diagnostics and 7.83% from other businesses [1] - As of the report, Kingmed Diagnostics has a market capitalization of 13.4 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation [1] - A new "slow bull" market pattern is emerging, indicating a shift in market dynamics [1]